Two companies have received approved for a generic of the 2.5 mg tablet of anticoagulant rivaroxaban, which is used to reduce ...

Supplemental Material is available at Supplemental Material. Correspondence to: Mingdong Huang, College of Chemistry, Fuzhou University, No. 2, Xueyuan Rd, New District, 350116 Fuzhou, Fujian, China ...

With the emergence and approval of other new oral anticoagulants such as dabigatran and rivaroxaban, the role of and place in therapy for all of these new agents will have to be clearly delineated ...